A Perimenopausal Woman With a Small, ER/HER2-Positive, Node-Negative Breast Cancer

被引：0
|
作者：
Brooks, Gabriel [6 ]
Borges, Virginia
Singh, Meenakshi [5 ]
Rabinovitch, Rachel [4 ]
Finlayson, Christina [3 ]
Elias, Anthony [1 ,2 ]
机构：
[1] Univ Colorado, Ctr Canc, Div Med Oncol, Sch Med, Aurora, CO 80045 USA
[2] Univ Colorado, Breast Canc Res Program, Sch Med, Aurora, CO 80045 USA
[3] Univ Colorado, Sch Med, Dept Surg, Aurora, CO 80045 USA
[4] Univ Colorado, Sch Med, Dept Radiat Oncol, Aurora, CO 80045 USA
[5] Univ Colorado, Sch Med, Dept Pathol, Aurora, CO 80045 USA
[6] Univ Colorado, Sch Med, Dept Med, Aurora, CO 80045 USA
来源：
ONCOLOGY-NEW YORK | 2008年 / 22卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1270 / 1276
页数：7
相关论文
共 50 条
  • [21] When and how to treat women with HER2-positive, small (pT1a-b), node-negative breast cancer?
    Gori, Stefania
    Turazza, Monica
    Modena, Alessandra
    Duranti, Simona
    Zamboni, Giuseppe
    Alongi, Filippo
    Carbognin, Giovanni
    Massocco, Alberto
    Salgarello, Matteo
    Inno, Alessandro
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 128 : 130 - 138
  • [22] Use of adjuvant trastuzumab with chemotherapy in women with small, node-negative, HER2-positive breast cancers.
    McArthur, H. L.
    Mahoney, K.
    Morris, P. G.
    Patil, S.
    Jacks, L. M.
    Howard, J.
    Norton, L.
    Hudis, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [23] Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer (vol 372, 134, 2015)
    不详
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (20): : 1989 - 1989
  • [24] The effect of trastuzumab-based therapy on overall survival in small, node-negative HER2-positive breast cancer: To treat or not to treat?
    van Ramshorst, M. S.
    van der Heijden-van der Loo, M.
    Dackus, G. M. H. E.
    Linn, S. C.
    Sonke, G. S.
    CANCER RESEARCH, 2016, 76
  • [25] The effect of trastuzumab-based therapy on overall survival in small, node-negative HER2-positive breast cancer: To treat or not to treat?
    van Ramshorst, M. S.
    van der Heijden-van der Loo, M.
    Dackus, G. M. H. E.
    Linn, S. C.
    Sonke, G. S.
    CANCER RESEARCH, 2016, 76
  • [26] T1b with ER negative, HER2-positive, and node-negative breast cancer patients might get benefit from adjuvant chemotherapy
    Altundag, Kadri
    JOURNAL OF BUON, 2020, 25 (05): : 2529 - 2530
  • [27] High recurrence risk and use of adjuvant trastuzumab in patients with small, HER2-positive, node-negative breast cancers
    Akiyo Horio
    Takashi Fujita
    Hironori Hayashi
    Masaya Hattori
    Naoto Kondou
    Mai Yamada
    Eri Adachi
    Aya Ushio
    Naomi Gondou
    Aiko Sueta
    Yasushi Yatabe
    Hiroji Iwata
    International Journal of Clinical Oncology, 2012, 17 : 131 - 136
  • [28] Impact of adjuvant trastuzumab (T) with chemotherapy on breast cancer specific and cardiac outcomes in older women with small, node-negative HER2-positive breast cancer
    Cadoo, K. A.
    Morris, P. G.
    Patil, S.
    Norton, L.
    Hudis, C. A.
    McArthur, H. L.
    CANCER RESEARCH, 2013, 73
  • [29] High recurrence risk and use of adjuvant trastuzumab in patients with small, HER2-positive, node-negative breast cancers
    Horio, Akiyo
    Fujita, Takashi
    Hayashi, Hironori
    Hattori, Masaya
    Kondou, Naoto
    Yamada, Mai
    Adachi, Eri
    Ushio, Aya
    Gondou, Naomi
    Sueta, Aiko
    Yatabe, Yasushi
    Iwata, Hiroji
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2012, 17 (02) : 131 - 136
  • [30] De-escalation of radiation therapy in patients with stage I, node-negative, HER2-positive breast cancer
    Jose G. Bazan
    Sachin R. Jhawar
    Daniel Stover
    Ko Un Park
    Sasha Beyer
    Erin Healy
    Julia R. White
    npj Breast Cancer, 7
12345